Annual Current Liabilities
$8.69 M
-$10.34 M-54.32%
31 December 2023
Summary:
Verona Pharma annual total current liabilities is currently $8.69 million, with the most recent change of -$10.34 million (-54.32%) on 31 December 2023. During the last 3 years, it has fallen by -$5.51 million (-38.80%). VRNA annual current liabilities is now -73.99% below its all-time high of $33.42 million, reached on 31 December 2021.VRNA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$27.95 M
-$20.40 M-42.19%
30 September 2024
Summary:
Verona Pharma quarterly total current liabilities is currently $27.95 million, with the most recent change of -$20.40 million (-42.19%) on 30 September 2024. Over the past year, it has increased by +$18.94 million (+210.14%). VRNA quarterly current liabilities is now -52.11% below its all-time high of $58.36 million, reached on 30 June 2021.VRNA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRNA Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -54.3% | +210.1% |
| 3 y3 years | -38.8% | +0.8% |
| 5 y5 years | -33.0% | +82.5% |
VRNA Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -74.0% | at low | -42.2% | +221.6% |
| 5 y | 5 years | -74.0% | at low | -52.1% | +221.6% |
| alltime | all time | -74.0% | >+9999.0% | -52.1% | >+9999.0% |
Verona Pharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $27.95 M(-42.2%) |
| June 2024 | - | $48.35 M(+227.2%) |
| Mar 2024 | - | $14.77 M(+70.0%) |
| Dec 2023 | $8.69 M(-54.3%) | $8.69 M(-3.6%) |
| Sept 2023 | - | $9.01 M(-17.7%) |
| June 2023 | - | $10.95 M(-58.7%) |
| Mar 2023 | - | $26.52 M(+39.4%) |
| Dec 2022 | $19.03 M(-43.1%) | $19.03 M(-40.8%) |
| Sept 2022 | - | $32.13 M(-17.3%) |
| June 2022 | - | $38.86 M(+2.5%) |
| Mar 2022 | - | $37.90 M(+13.4%) |
| Dec 2021 | $33.42 M(+135.3%) | $33.42 M(+20.5%) |
| Sept 2021 | - | $27.74 M(-52.5%) |
| June 2021 | - | $58.36 M(+359.6%) |
| Mar 2021 | - | $12.70 M(-10.6%) |
| Dec 2020 | $14.20 M(+10.6%) | $14.20 M(-15.8%) |
| Sept 2020 | - | $16.86 M(+61.9%) |
| June 2020 | - | $10.41 M(+4.9%) |
| Mar 2020 | - | $9.93 M(-22.7%) |
| Dec 2019 | $12.84 M(-1.0%) | $12.84 M(-16.2%) |
| Sept 2019 | - | $15.32 M(+24.2%) |
| June 2019 | - | $12.33 M(+58.2%) |
| Mar 2019 | - | $7.79 M(-40.0%) |
| Dec 2018 | $12.97 M(+11.7%) | $12.97 M(-4.2%) |
| Sept 2018 | - | $13.54 M(-19.0%) |
| June 2018 | - | $16.71 M(-26.8%) |
| Mar 2018 | - | $22.82 M(+96.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $11.62 M(-13.4%) | $11.62 M(-1.8%) |
| Sept 2017 | - | $11.83 M(+10.6%) |
| June 2017 | - | $10.69 M(-20.3%) |
| Dec 2016 | $13.41 M(+399.5%) | $13.41 M(+694.9%) |
| June 2016 | - | $1.69 M(-37.2%) |
| Dec 2015 | $2.69 M(+229.1%) | $2.69 M(+199.0%) |
| June 2015 | - | $898.30 K(+10.1%) |
| Dec 2014 | $816.10 K(+1.1%) | $816.10 K(+18.2%) |
| June 2014 | - | $690.40 K(-14.4%) |
| Dec 2013 | $806.90 K(+150.5%) | $806.90 K(+204.1%) |
| June 2013 | - | $265.30 K(-17.6%) |
| Dec 2012 | $322.10 K(+33.0%) | $322.10 K(+105.0%) |
| June 2012 | - | $157.10 K(-35.1%) |
| Dec 2011 | $242.20 K(-23.8%) | $242.20 K(-47.3%) |
| June 2011 | - | $459.70 K(+44.6%) |
| Dec 2010 | $317.90 K(-31.5%) | $317.90 K(+225.1%) |
| June 2010 | - | $97.80 K(-78.9%) |
| Dec 2009 | $464.10 K(+277.3%) | $464.10 K(+394.8%) |
| June 2009 | - | $93.80 K(-23.7%) |
| Dec 2008 | $123.00 K(-60.5%) | $123.00 K(-79.0%) |
| June 2008 | - | $587.10 K(+88.5%) |
| Dec 2007 | $311.40 K(+140.8%) | $311.40 K(+121.5%) |
| June 2007 | - | $140.60 K(+8.7%) |
| Dec 2006 | $129.30 K(+527.7%) | $129.30 K(-47.8%) |
| June 2006 | - | $247.60 K(+1101.9%) |
| Dec 2005 | $20.60 K | $20.60 K(+64.8%) |
| June 2005 | - | $12.50 K |
FAQ
- What is Verona Pharma annual total current liabilities?
- What is the all time high annual current liabilities for Verona Pharma?
- What is Verona Pharma annual current liabilities year-on-year change?
- What is Verona Pharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Verona Pharma?
- What is Verona Pharma quarterly current liabilities year-on-year change?
What is Verona Pharma annual total current liabilities?
The current annual current liabilities of VRNA is $8.69 M
What is the all time high annual current liabilities for Verona Pharma?
Verona Pharma all-time high annual total current liabilities is $33.42 M
What is Verona Pharma annual current liabilities year-on-year change?
Over the past year, VRNA annual total current liabilities has changed by -$10.34 M (-54.32%)
What is Verona Pharma quarterly total current liabilities?
The current quarterly current liabilities of VRNA is $27.95 M
What is the all time high quarterly current liabilities for Verona Pharma?
Verona Pharma all-time high quarterly total current liabilities is $58.36 M
What is Verona Pharma quarterly current liabilities year-on-year change?
Over the past year, VRNA quarterly total current liabilities has changed by +$18.94 M (+210.14%)